Dr. Sheikh Asim Ali, MD

Dr. Ali practices at Lehigh Valley Hospital-Pocono in East Stroudsburg, Pennsylvania, part of Thomas Jefferson University.

Dr. Ali's NPI, 1285830265, was assigned on June 26, 2007. Dr. Ali graduated from Aga Khan Medical College in 1998. Dr. Ali holds Pennsylvania license MD433379.

Dr. Ali's primary practice is Lehigh Valley Hospital-Pocono, at 206 East Brown Street, East Stroudsburg, PA 18301 in Monroe County. The practice phone is (570) 421-4000.

Dr. Ali's primary practice is Lehigh Valley Hospital-Pocono in East Stroudsburg, Pennsylvania, part of Thomas Jefferson University. Dr. Ali is also affiliated with Lehigh Valley Hospital-Cedar Crest. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Ali to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ali practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ali's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ali is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ali's licenses on file in 4 states: Pennsylvania, Maine, New Jersey and Ohio.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Ali treats.

CMS data shows 617 Medicare services from Dr. Ali across 5 procedure codes in 2024, for 295 Medicare patients. Medicare paid $51,082 for them.

CMS counts 295 Medicare patients who saw Dr. Ali in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ali's median patient age at 66, with 60% women.

In 2024, Dr. Ali wrote 483 Medicare Part D claims for 142 patients. 81% of them were for generic drugs. CMS names the drug for 334 of them, across 11 drugs with 11 or more claims each, at $646,054 in total drug cost. In 2023, CMS named 287 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Ali for performance year 2024, reported as part of a group. Dr. Ali accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Ali in 2012. 2012 was the busiest year, with 2. Dr. Ali's most frequent co-authors are Rajesh Sehgal, MD, David M. Friedland and Wassim M. McHayleh, MD.

Dmand AI links Dr. Ali to 5 clinical trials, 3 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Adenocarcinoma Of Esophagus, Anal Canal Carcinoma and Colorectal Neoplasms, Hereditary Nonpolyposis. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 163 general payments to Dr. Ali from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $1,317.

Dmand AI lists 1 award for Dr. Ali, most recently CMS Stage 1 EHR in 2013.

Dr. Ali graduated from Aga Khan Medical College in 1998.

Dr. Ali is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 13. Check the plan with the practice before a visit.